RIOK2 and glioblastoma: Here, we investigated the anti-glioblastoma effects of RIOK2 inhibitor NSC139021 and found that it inhibited the viability and proliferation of human and mouse glioblastoma cells via a mechanism independent of RIOK2 and other RIO kinases.